ApprovalTrail

Approval · Notice of Compliance 32283 · 2023

ACAM2000: Notice of Compliance 32283

Issued December 5, 2023

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
32283
Date
December 5, 2023
Company
Emergent Product Development Gaithersburg Inc.Gaithersburg, Maryland, United States
Product type
Biologic
Submission
New Drug Submission (NDS)
Submission class
Other

Products in this notice

BrandDINStatus today
ACAM200002543699Restricted Access

Medicinal ingredients